Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1996 Dec;49(6):M351–M356. doi: 10.1136/mp.49.6.m351

Significantly reduced expression of the proteoglycan decorin in Alzheimer's disease fibroblasts

Enrique Brandan 1, Francisco Melo 1, María García 1, Maribel Contreras 1
PMCID: PMC408086  PMID: 16696102

Abstract

Aims—To investigate whether proteoglycan synthesis is altered in skin fibroblasts in patients with Alzheimer's disease compared with normal subjects.

Methods—Cell lines obtained from donors with Alzheimer's disease and healthy controls were incubated with radioactive sulphate. The proteoglycans synthesised were determined and analysed by chromatographic, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and glycosaminoglycans-lyase treatment. The amount of decorin synthesised by each cell line was quantified using western blot analysis. Transcripts for human decorin were determined using northern blot analysis.

Results—No significant changes in total sulphate incorporation and glycos-aminoglycan (GAG) composition were detected in the incubation media of these cells. However, chromatographic and SDS-PAGE analysis of the proteoglycans secreted by the cell lines showed that a dermatan sulphate proteoglycan of 150-125 kilodaltons was substantially reduced in Alzheimer's disease fibroblasts. The molecular characteristics of this proteoglycan correspond to decorin. Western blot analysis indicated that decorin was reduced in Alzheimer's disease incubation medium compared with normal medium. Northern blotting indicated that in Alzheimer's disease fibroblasts decorin transcripts were significantly reduced compared with normal fibroblasts. Glypican concentrations, a cell surface heparan sulphate proteoglycan, remained the same.

Conclusions—These results strongly suggest that the expression and synthesis of decorin is affected in Alzheimer's disease skin fibroblasts.

Keywords: proteoglycans

Keywords: decorin

Keywords: cell adhesion

Keywords: Alzheimer's disease

Keywords: fibroblasts

Full text

PDF
M351

Images in this article

M353Image
on p.M353
M354Image
on p.M354
M355Image
on p.M355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balin A. K., Baker A. C., Leong I. C., Blass J. P. Normal replicative lifespan of Alzheimer skin fibroblasts. Neurobiol Aging. 1988 Mar-Apr;9(2):195–198. doi: 10.1016/s0197-4580(88)80050-2. [DOI] [PubMed] [Google Scholar]
  2. Bernfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol. 1992;8:365–393. doi: 10.1146/annurev.cb.08.110192.002053. [DOI] [PubMed] [Google Scholar]
  3. Blass J. P., Baker A. C., Ko L., Sheu R. K., Black R. S. Expression of 'Alzheimer antigens' in cultured skin fibroblasts. Arch Neurol. 1991 Jul;48(7):709–717. doi: 10.1001/archneur.1991.00530190055016. [DOI] [PubMed] [Google Scholar]
  4. Brandan E., Fuentes M. E., Andrade W. The proteoglycan decorin is synthesized and secreted by differentiated myotubes. Eur J Cell Biol. 1991 Aug;55(2):209–216. [PubMed] [Google Scholar]
  5. Brandan E., Inestrosa N. C. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. Gen Pharmacol. 1993 Sep;24(5):1063–1068. doi: 10.1016/0306-3623(93)90350-7. [DOI] [PubMed] [Google Scholar]
  6. Campos A., Núez R., Koenig C. S., Carey D. J., Brandan E. A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells. Isolation and biochemical characterization. Eur J Biochem. 1993 Sep 1;216(2):587–595. doi: 10.1111/j.1432-1033.1993.tb18178.x. [DOI] [PubMed] [Google Scholar]
  7. Carey D. J., Stahl R. C., Cizmeci-Smith G., Asundi V. K. Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J Cell Biol. 1994 Jan;124(1-2):161–170. doi: 10.1083/jcb.124.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clark E. A., Brugge J. S. Integrins and signal transduction pathways: the road taken. Science. 1995 Apr 14;268(5208):233–239. doi: 10.1126/science.7716514. [DOI] [PubMed] [Google Scholar]
  9. Fillit H., Leveugle B. Disorders of the extracellular matrix and the pathogenesis of senile dementia of the Alzheimer's type. Lab Invest. 1995 Mar;72(3):249–253. [PubMed] [Google Scholar]
  10. Fisher L. W., Termine J. D., Dejter S. W., Jr, Whitson S. W., Yanagishita M., Kimura J. H., Hascall V. C., Kleinman H. K., Hassell J. R., Nilsson B. Proteoglycans of developing bone. J Biol Chem. 1983 May 25;258(10):6588–6594. [PubMed] [Google Scholar]
  11. Font B., Aubert-Foucher E., Goldschmidt D., Eichenberger D., van der Rest M. Binding of collagen XIV with the dermatan sulfate side chain of decorin. J Biol Chem. 1993 Nov 25;268(33):25015–25018. [PubMed] [Google Scholar]
  12. Glenner G. G., Wong C. W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1131–1135. doi: 10.1016/0006-291x(84)91209-9. [DOI] [PubMed] [Google Scholar]
  13. Glössl J., Beck M., Kresse H. Biosynthesis of proteodermatan sulfate in cultured human fibroblasts. J Biol Chem. 1984 Nov 25;259(22):14144–14150. [PubMed] [Google Scholar]
  14. Hanemann C. O., Kuhn G., Lie A., Gillen C., Bosse F., Spreyer P., Müller H. W. Expression of decorin mRNA in the nervous system of rat. J Histochem Cytochem. 1993 Sep;41(9):1383–1391. doi: 10.1177/41.9.8354878. [DOI] [PubMed] [Google Scholar]
  15. Hardingham T. E., Fosang A. J. Proteoglycans: many forms and many functions. FASEB J. 1992 Feb 1;6(3):861–870. [PubMed] [Google Scholar]
  16. Hildebrand A., Romarís M., Rasmussen L. M., Heinegård D., Twardzik D. R., Border W. A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J. 1994 Sep 1;302(Pt 2):527–534. doi: 10.1042/bj3020527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Joachim C. L., Mori H., Selkoe D. J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature. 1989 Sep 21;341(6239):226–230. doi: 10.1038/341226a0. [DOI] [PubMed] [Google Scholar]
  18. Krusius T., Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7683–7687. doi: 10.1073/pnas.83.20.7683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Melo F., Brandan E. Decorin is specifically solubilized by heparin from the extracellular matrix of rat skeletal muscles. FEBS Lett. 1993 Mar 22;319(3):249–252. doi: 10.1016/0014-5793(93)80556-a. [DOI] [PubMed] [Google Scholar]
  20. Narindrasorasak S., Lowery D., Gonzalez-DeWhitt P., Poorman R. A., Greenberg B., Kisilevsky R. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J Biol Chem. 1991 Jul 15;266(20):12878–12883. [PubMed] [Google Scholar]
  21. Roughley P. J., White R. J. Dermatan sulphate proteoglycans of human articular cartilage. The properties of dermatan sulphate proteoglycans I and II. Biochem J. 1989 Sep 15;262(3):823–827. doi: 10.1042/bj2620823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem. 1989 Aug 15;264(23):13369–13372. [PubMed] [Google Scholar]
  23. Schubert D., LaCorbiere M., Saitoh T., Cole G. Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2066–2069. doi: 10.1073/pnas.86.6.2066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sims N. R., Finegan J. M., Blass J. P. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann Neurol. 1987 May;21(5):451–457. doi: 10.1002/ana.410210507. [DOI] [PubMed] [Google Scholar]
  25. Small D. H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K., Masters C. L. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci. 1994 Apr;14(4):2117–2127. doi: 10.1523/JNEUROSCI.14-04-02117.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Snow A. D., Mar H., Nochlin D., Kresse H., Wight T. N. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J Histochem Cytochem. 1992 Jan;40(1):105–113. doi: 10.1177/40.1.1370306. [DOI] [PubMed] [Google Scholar]
  27. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron. 1994 Jan;12(1):219–234. doi: 10.1016/0896-6273(94)90165-1. [DOI] [PubMed] [Google Scholar]
  28. Takahashi T., Cho H. I., Kublin C. L., Cintron C. Keratan sulfate and dermatan sulfate proteoglycans associate with type VI collagen in fetal rabbit cornea. J Histochem Cytochem. 1993 Oct;41(10):1447–1457. doi: 10.1177/41.10.8245404. [DOI] [PubMed] [Google Scholar]
  29. Takeda M., Tanaka M., Kudo T., Nakamura Y., Tada K., Nishimura T. Changes in adhesion efficiency and vimentin distribution of fibroblasts from familial Alzheimer's disease patients. Acta Neurol Scand. 1990 Oct;82(4):238–244. doi: 10.1111/j.1600-0404.1990.tb01613.x. [DOI] [PubMed] [Google Scholar]
  30. Takeda M., Tatebayashi Y., Nishimura T. Change in the cytoskeletal system in fibroblasts from patients with familial Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1992 May;16(3):317–328. doi: 10.1016/0278-5846(92)90083-q. [DOI] [PubMed] [Google Scholar]
  31. Takeuchi Y., Kodama Y., Matsumoto T. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J Biol Chem. 1994 Dec 23;269(51):32634–32638. [PubMed] [Google Scholar]
  32. Winnemöller M., Schmidt G., Kresse H. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol. 1991 Feb;54(1):10–17. [PubMed] [Google Scholar]
  33. Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990 Jul 19;346(6281):281–284. doi: 10.1038/346281a0. [DOI] [PubMed] [Google Scholar]
  34. Zebrower M., Beeber C., Kieras F. J. Characterization of proteoglycans in Alzheimer's disease fibroblasts. Biochem Biophys Res Commun. 1992 May 15;184(3):1293–1300. doi: 10.1016/s0006-291x(05)80023-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES